[1]郭杨杨,余加林.肺表面活性物质在重症新生儿呼吸窘迫综合征中的应用[J].医学信息,2018,31(09):42-45.[doi:10.3969/j.issn.1006-1959.2018.09.014]
　GUO Yang-yang,YU Jia-lin.Application of Pulmonary Surfactant in Severe Neonatal Respiratory Distress Syndrome[J].Journal of Medical Information,2018,31(09):42-45.[doi:10.3969/j.issn.1006-1959.2018.09.014]
点击复制

肺表面活性物质在重症新生儿呼吸窘迫综合征中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年09期
页码:
42-45
栏目:
综述
出版日期:
2018-05-01

文章信息/Info

Title:
Application of Pulmonary Surfactant in Severe Neonatal Respiratory Distress Syndrome
文章编号:
1006-1959（2018）09-0042-04
作者:
郭杨杨; 余加林
重庆医科大学附属儿童医院新生儿科，重庆 400000
Author(s):
GUO Yang-yang; YU Jia-lin
Department of Pediatrics,Children's Hospital Affiliated to Medical University Of Chongqing,Chongqing 400000,China
关键词:
重症; 新生儿呼吸窘迫综合征; 肺表面活性物质
Keywords:
Key words：Severe; Neonatal respiratory distress syndrome; Pulmonary surfactant
分类号:
R722.1
DOI:
10.3969/j.issn.1006-1959.2018.09.014
文献标志码:
A
摘要:
肺表面活性物质作为新生儿呼吸窘迫综合征的针对病因的特效医治措施，已成为其标准治疗手段之一，有效降低了新生儿呼吸窘迫综合征的并发症发生率及死亡率，但重症新生儿呼吸窘迫综合征仍是引起新生儿残疾和死亡最常见的疾病，因而应重视新生儿呼吸窘迫综合征严重度的评价，并制订出适用于重症新生儿呼吸窘迫综合征的治疗方案。
Abstract:
Abstract：Pulmonary surfactant has became one of the standard treatment methods for neonatal respiratory distress syndrome.The incidence of complications and mortality of neonatal respiratory distress syndrome were reduced effectively,but severe neonatal respiratory distress syndrome was still the most common disease causing neonatal disability and death.Therefore,attention should be paid to the evaluation of the severity of neonatal respiratory distress syndrome,and a treatment plan for severe neonatal respiratory distress syndrome should be worked out.

参考文献/References:

[1]Nashwa El-Gendy,Anubhav Kaviratna,Cory Berkland,et al.Delivery and performance of surfactant replacement therapies to treat pulmonary disorders[J].Ther Deliv,2013,4(8):951-980.
[2]谢露,尹晓娟.新生儿肺表面活性物质研究新进展[J].中国儿童保健杂志,2012,20(3): 235-237.
[3]Sweet D,Carnielli V,Greisen G,et al.European consensus guidelines on the management of neonatal respiratory distress syndrome-2016 Update[J].Neonatology,2017,111(2):107-125.
[4]Walsh BK,DaBlasi RM,Restrepo RD.American Association for Respiratory Care.AARC clinical practice guideline.surfactant replacement therapy:2013[J].Respir Care,2013,58(2):367-375.
[5]王卫平,毛萌,李廷玉,等.儿科学.第8版[M].北京:人民卫生出版社,2013:115-118.
[6]王英兰,苏放明,魏晓萍,等.肺表面活性物质羊膜腔注射预防早产儿呼吸窘迫综合征的疗效及药物浓度分析[J].现代妇产科进展,2012,21(03):189-192.
[7]Agarwal N,Bathwal S,Kriplani A,et al.Intra-amniotic instillation of surfactants for the prevention of neonatal respiratory distress syndrome following preterm delivery[J].International Journal of Gynecology and Obstetrics,2016,135(2):196-199.
[8]Sweet D,Carnielli V,Greisen G,et al.European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants[J].Neonatology,2013,103(4):353-368.
[9]Rebello CM,Proen?揶a RS,Troster EJ,et al.Exogenous surfactant therapy-What is established and what still needs to be determined[J].J Pediatr(Rio J),2012,78(Suppl.2):s215-s226.
[10]David W A Milligan.Surfactant therapy for respiratory distress syndrome in premature neonates:a comparative review[J].Am J Respir Med,2002,1(6):417-433.
[11]陈超.新生儿呼吸窘迫综合征[M]//邵肖梅,叶红瑁,丘小汕.实用新生儿科学.第4版.北京:人民卫生出版社,2011:395-398.
[12]于红奎,夏焙,黄惠君,等.肺超声评分评估新生儿呼吸窘迫综合征肺病变及预后的可行性及临床意义[J].中国医学影像技术,2017,33(08):1216-1220.
[13]Matthew Hiles,Anne-Marie Culpan,Catriona Watts,et al.Chest X-ray or lung ultrasound A systematic review[J].Ultrasound,2017,25(2):80-91.
[14]Villar J,Kacmarek RM.The American-European Consensus Conference definition of the ARDS is dead,long live PEEP[J].Med Intensiva,2012,36(8):571-575.
[15]Daniele De Luca,Marco Piastra,Giovanna Chidini,et al.The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood:multicenter evaluation and expert consensus[J].Intensive Care Med,2013 ,39(12):2083-2091.
[16]Khemani RG,Wilson DF,Esteban A,et al.Evaluating the Berlin Definition in pediatric ARDS[J].Intensive Care Med,2013,39(12):2213-2216.
[17]王新东.大剂量珂立苏治疗重症新生儿呼吸窘迫综合征的疗效观察[J]. 临床医药文献电子杂志,2016,3(30):6065,6068.
[18]Tsakalidis C,Giougki E,Karagianni P,et al.Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants[J].The Turkish Journal of Pediatrics,2012,54(4):368-375.
[19]Nayeri FS,Esmaeilnia Shirvani T,Aminnezhad M,et al.Comparison of INSURE Method with Conventional Mechanical Ventilation after Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome:Therapeutic Challenge[J].Acta Med Iran,2014,52(8):596-600.
[20]徐芬,罗俊,黎红平,等.LISA技术治疗新生儿呼吸窘迫综合征有效性的系统评价[J].临床儿科杂志,2017,35(03):223-228.
[21]田淑娟,刘呈祥,武振河.不同程度新生儿肺透明膜病的治疗手段及疗效分析[J].临床肺科杂志,2012,17(9):1682-1683.
[22]肖厚兰,林多华,孙世兰,等.经鼻双水平正压通气模式联合咖啡因治疗极低出生体重儿呼吸暂停的临床研究[J]. 发育医学电子杂志,2017,5(01):18-21.
[23]中国医师协会新生儿科医师分会.早产儿呼吸窘迫综合征早期防治专家共识[J].发育医学电子杂志,2017,5(03):129-131.

相似文献/References:

[1]郭剑波.限制热卡营养早期应用于ICU内科重症成年患者的效果研究[J].医学信息,2018,31(03):112.[doi:10.3969/j.issn.1006-1959.2018.03.037]
　GUO Jian-bo.Effect of Early Application of Restricted Calorie Nutrition on Severe Adult Patients in ICU Department of Internal Medicine[J].Journal of Medical Information,2018,31(09):112.[doi:10.3969/j.issn.1006-1959.2018.03.037]
[2]覃 艺,邓燕艺,赖昌生,等.554例儿童重症手足口病的临床特征分析[J].医学信息,2018,31(11):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
　QIN Yi,DENG Yan-yi,LAI Chang-sheng,et al.Analysis of Clinical Features of Severe Hand Foot and Mouth Disease in 554 Children[J].Journal of Medical Information,2018,31(09):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
[3]董桂芬,胡丽红,马得宏,等.西双版纳中、老、缅边境地区登革热的护理干预[J].医学信息,2018,31(11):167.[doi:10.3969/j.issn.1006-1959.2018.11.055]
　DONG Gui-fen,HU Li-hong,MA De-hong,et al.Nursing Intervention of Dengue Fever in Central,Old and Myanmar Border Areas of Xishuangbanna[J].Journal of Medical Information,2018,31(09):167.[doi:10.3969/j.issn.1006-1959.2018.11.055]
[4]王 瑜.猪肺磷脂注射液联合无创通气治疗新生儿呼吸窘迫综合征的疗效[J].医学信息,2022,35(10):143.[doi:10.3969/j.issn.1006-1959.2022.10.035]
　WANG Yu.Effect of Porcine Pulmonary Phospholipid Injection Combined with Noninvasive Ventilation on Neonatal Respiratory Distress Syndrome[J].Journal of Medical Information,2022,35(09):143.[doi:10.3969/j.issn.1006-1959.2022.10.035]
[5]谢 鹏,曹海泉,尚 娟,等.重症急性胰腺炎患者肠内营养的时机选择[J].医学信息,2018,31(17):81.[doi:10.3969/j.issn.1006-1959.2018.17.024]
　XIE Peng,CAO Hai-quan,SHANG Juan,et al.Timing of Enteral Nutrition in Patients with Severe Acute Pancreatitis[J].Journal of Medical Information,2018,31(09):81.[doi:10.3969/j.issn.1006-1959.2018.17.024]
[6]林振涛.重症社区获得性肺炎的诊治[J].医学信息,2019,32(22):43.[doi:10.3969/j.issn.1006-1959.2019.22.014]
　LIN Zhen-tao.Diagnosis and Treatment of Severe Community Acquired Pneumonia[J].Journal of Medical Information,2019,32(09):43.[doi:10.3969/j.issn.1006-1959.2019.22.014]
[7]钱元原.肺表面活性物质联合CPAP治疗NRDS的疗效[J].医学信息,2019,32(24):105.[doi:10.3969/j.issn.1006-1959.2019.24.035]
　QIAN Yuan-yuan.Efficacy of Pulmonary Surfactant Combined with CPAP in the Treatment of Neonatal Respiratory Distress Syndrome[J].Journal of Medical Information,2019,32(09):105.[doi:10.3969/j.issn.1006-1959.2019.24.035]
[8]宋予苹,魏 来,陈 斌.BiPAP联合rhBNP在重症AHF抢救治疗中的应用[J].医学信息,2020,33(07):152.[doi:10.3969/j.issn.1006-1959.2020.07.049]
　SONG Yu-ping,WEI Lai,CHEN Bin.Application of BiPAP Combined with rhBNP in Rescue Treatment of Severe AHF[J].Journal of Medical Information,2020,33(09):152.[doi:10.3969/j.issn.1006-1959.2020.07.049]
[9]陈勃宇,许程飞.床旁连续性血液净化治疗重症急性胰腺炎患者的针对性护理[J].医学信息,2020,33(21):174.[doi:10.3969/j.issn.1006-1959.2020.21.055]
　CHEN Bo-yu,XU Cheng-fei.Targeted Nursing Care of Patients with Severe Acute Pancreatitis Treated by Bedside Continuous Blood Purification[J].Journal of Medical Information,2020,33(09):174.[doi:10.3969/j.issn.1006-1959.2020.21.055]
[10]童 玲,王慧琴.基于Logistic回归模型的足月新生儿呼吸窘迫综合征相关因素分析[J].医学信息,2020,33(19):91.[doi:10.3969/j.issn.1006-1959.2020.19.026]
　TONG Ling,WANG Hui-qin.Analysis of Related Factors of Full-term Neonatal Respiratory Distress Syndrome Based on Logistic Regression Model[J].Journal of Medical Information,2020,33(09):91.[doi:10.3969/j.issn.1006-1959.2020.19.026]

更新日期/Last Update: 2018-05-01